Johnson & Johnson (JNJ)

136.34
NYSE : Health Care
Prev Close 136.34
Day Low/High 0.00 / 0.00
52 Wk Low/High 109.32 / 137.00
Avg Volume 5.70M
Exchange NYSE
Shares Outstanding 2.69B
Market Cap 367.52B
EPS 6.00
P/E Ratio 22.93
Div & Yield 3.36 (2.50%)

Latest News

What Apple, Microsoft and Some of the World's Biggest Tech Companies Are Doing Now in Healthcare

What Apple, Microsoft and Some of the World's Biggest Tech Companies Are Doing Now in Healthcare

Players include Apple, Google, Microsoft and Samsung.

Samsung Could Sell More Drugs

Samsung Could Sell More Drugs

Samsung's Bioepis unit seeks final approval in Europe of a rheumatoid arthritis drug to compete with Humira.

FDA Commisoner Takes on Big Pharma

FDA Commisoner Takes on Big Pharma

Investors should watch these companies come July 18th.

Cramer: This Is No Country for Old Value

Cramer: This Is No Country for Old Value

Down-and-out stocks have become toxic.

Dems Roast Trump for Leaving Medicare Out of Drug Price Order

Dems Roast Trump for Leaving Medicare Out of Drug Price Order

The main thrust of the order appears to be easing regulatory hurdles to drug approvals, which could lower the cost of bringing new treatments to market and thus lower prices.

Major Talc Case Against J&J Declared a Mistrial Following SCOTUS Ruling

Major Talc Case Against J&J Declared a Mistrial Following SCOTUS Ruling

The court ruled that state courts can't hear claims against an out-of-state company if the alleged injuries didn't occur there.

Douglas Wallace, Ph.D., Wins 2017 Dr. Paul Janssen Award For Biomedical Research

Johnson & Johnson Launches Campaign for Champions of Science

Alibaba and Tencent Could One Day Be Bigger Than Apple

Alibaba and Tencent Could One Day Be Bigger Than Apple

China's tech giants Alibaba and Tencent now rank among the 10 largest companies in the world. How long before they're 1 and 2?

These 7 Companies Are Finding Strength In a Weak Dollar, Jim Cramer Explains

These 7 Companies Are Finding Strength In a Weak Dollar, Jim Cramer Explains

Companies worth your attention.

Jim Cramer: Another Rotation Out of Apple and Nvidia Is in the Cards

Jim Cramer: Another Rotation Out of Apple and Nvidia Is in the Cards

We forget that a big hedge fund or mutual fund switching out of tech winners into everything else can roil the market.

On Betting Against the Bonds and Panicking off the Fed: Jim Cramer's Best Blog

On Betting Against the Bonds and Panicking off the Fed: Jim Cramer's Best Blog

Jim Cramer discusses bonds and also talks about why panicking off the Fed is a superbad idea.

Google and Novartis Back Medicxi's New $300 Million Fund

Google and Novartis Back Medicxi's New $300 Million Fund

Developing a promising drug? This new investment fund is looking to invest in Phase 2 candidates.

Cramer: You Can't Bet Against the Bonds

Cramer: You Can't Bet Against the Bonds

A rotation that started as the minor chord of the rotational symphony and is now the major one.

Johnson & Johnson Announces Completion Of Acquisition Of Actelion

Transaction Expands Janssen Portfolio with Leading Differentiated In-Market Medicines and Promising Late-Stage Therapies

Epizyme's Positive Cancer Drug Results Likely to Catch the Eye of Celgene, J&J

Epizyme's Positive Cancer Drug Results Likely to Catch the Eye of Celgene, J&J

Epizyme sank almost 20% since their last earnings report, but recent developments show positive data from one of its keynote drugs, Tazemetostat

This Is What Sector Rotation Looks Like

This Is What Sector Rotation Looks Like

There's a herd mentality around FANG stocks, but herds tend to change direction quickly.

Opioid Marketing Under Bipartisan Investigation

Opioid Marketing Under Bipartisan Investigation

Individual state investigations of opioid marketing practices has lead to a multistate investigation of the prescription painkiller industry.

Cramer: The Rotation Out of Apple and Nvidia Can Happen Again Today

Cramer: The Rotation Out of Apple and Nvidia Can Happen Again Today

We forget that a big hedge fund or mutual fund switching out of tech winners into everything else can roil the market.

Johnson & Johnson Sees Success with Flu Treatment Trial

Johnson & Johnson Sees Success with Flu Treatment Trial

The study showed that treatment with pimodivir alone resulted in significant reduction in the viral load in patients being treated over seven days.

Navigating Strong Crosscurrents: Cramer's 'Mad Money' Recap (Tuesday 6/13/17)

Navigating Strong Crosscurrents: Cramer's 'Mad Money' Recap (Tuesday 6/13/17)

Jim Cramer says the markets could be further rattled by the Federal Reserve meeting.

Cramer: A Funny Thing Happened on the Way to the Selloff

Cramer: A Funny Thing Happened on the Way to the Selloff

This market has diverged from some of its usual patterns.

Google Says It 'Will Not Rest' Until Its YouTube Ad Crisis Is Over

Google Says It 'Will Not Rest' Until Its YouTube Ad Crisis Is Over

Google has attracted most brands back to its site after ads ran next to neo-Nazi and jihadist videos, but it's still hoping for some big players to return.

Cramer: These Companies Find Strength in a Weak Dollar

Cramer: These Companies Find Strength in a Weak Dollar

Looking for growth overseas? You're not seeing triple, you're seeing 3M.

Regulus, AstraZeneca Cut Ties on Liver Disease Treatment, Shares Dip

Regulus, AstraZeneca Cut Ties on Liver Disease Treatment, Shares Dip

After Regulus dropped two of its drug programs, AstraZeneca ditched the duo's drug partnership, too.

These Three U.S. Companies Storing Billions Overseas Account for Half of all U.S. Offshore Profits

These Three U.S. Companies Storing Billions Overseas Account for Half of all U.S. Offshore Profits

Trump has proposed a plan to repatriate the money.